Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.

SHREVEPORT, La. - A new drug developed by Eli Lily works in a unique way compared to treatments already on the market, like ...

SHREVEPORT, La. - A new drug developed by Eli lily works in a unique way compared to treatments already on the market, like ...

The Hunting Wives' actress Chrissy Metz gets candid in a new cover story for PEOPLE on her thoughts about using weight loss ...

Combining liraglutide with a very low-calorie ketogenic diet can lead to greater weight loss than the diet alone in adults ...

New research suggests popular weight loss drugs like Ozempic and Wegovy may affect more than just fat, raising questions about muscle strength and organ size after significant weight loss. University ...

Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...

What is being described as a groundbreaking discussion in the medical industry is linking hearing loss with dementia.

More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...

Scientists have found that cutting cysteine triggers fat to burn energy instead of storing it. This shift from white to brown ...

Q2 2025 Earnings Call Transcript August 5, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $6.02, expectations ...